(Q45360099)

13 December 2017

0 references

Hepatitis B virus vaccine in chronic kidney disease: improved immunogenicity by adjuvants? A meta-analysis of randomized trials (English)

1 reference

chronic renal insufficiency

13 December 2017

1 reference

1 reference

3

Piergiorgio Messa

1 reference

13 December 2017

1

Fabrizio Fabrizi

1 reference

13 December 2017

Vivek Dixit

2

1 reference

13 December 2017

Paul Martin

series ordinal

4

1 reference

13 December 2017

language of work or name

English

0 references

publication date

26 January 2012

1 reference

13 December 2017

1 reference

13 December 2017

volume

30

1 reference

13 December 2017

issue

13

1 reference

13 December 2017

page(s)

2295-2300

1 reference

Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: the DOPPS

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.064

National surveillance of dialysis-associated diseases in the United States, 2002.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.064

Nonhospital health care-associated hepatitis B and C virus transmission: United States, 1998-2008.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.064

Elevated prevalence of hepatitis B in Mexican hemodialysis patients. A multicentric survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.064

Chronic viral hepatitis and the management of chronic renal failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.064

Hepatitis B virus infection in chronic uremia: long-term follow-up of a two-step integrated protocol of vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.064

Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: earlier is better

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.064

Controlled trial of thymopentin in hemodialysis patients who fail to respond to hepatitis B vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.064

Peripheral blood dendritic cells and GM-CSF as an adjuvant for hepatitis B vaccination in hemodialysis patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.064

A new adjuvant improves the immune response to hepatitis B vaccine in hemodialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.064

The retrieval of randomized clinical trials in liver disease from the medical literature. A comparison of MEDLARS and manual methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.064

Meta-analysis in clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.064

Measuring inconsistency in meta-analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.064

Approaches to heterogeneity in meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.064

A note on graphical presentation of estimated odds ratios from several clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.064

Total parenteral nutrition and cancer clinical trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.064

Recombinant gamma-interferon as adjuvant to hepatitis B vaccine in hemodialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.064

Randomised placebo-controlled trial of recombinant interleukin-2 in chronic uraemic patients who are non-responders to hepatitis B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.064

AM3 (Inmunoferón) as an adjuvant to hepatitis B vaccination in hemodialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.064

Efficacy of GM-CSF as an Adjuvant to Hepatitis B Vaccination in Patients with Chronic Renal Failure—Results of a Prospective, Randomized Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.064

Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.064

Effect of levamisole supplementation on hepatitis B virus vaccination response in hemodialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.064

Recombinant interferon-alpha2b improves immune response to hepatitis B vaccination in haemodialysis patients: results of a randomised clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.064

Immunogenicity and safety of an investigational AS02(v)-adjuvanted hepatitis B vaccine in patients with renal insufficiency who failed to respond or to maintain antibody levels after prior vaccination: results of two open, randomized, comparative tr

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.064

Immunologic defects and vaccination in patients with chronic renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.064

Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.064

Antibody level after hepatitis B vaccination in hemodialysis patients: influence of hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.064

Hepatitis B vaccination in human immunodeficiency virus-infected adults receiving hemodialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.064

The effect of diabetes mellitus on immunological response to hepatitis B virus vaccine in individuals with chronic kidney disease: A meta-analysis of current literature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.064

Treatment with recombinant human erythropoietin increases antibody titers after hepatitis B vaccination in dialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.064

Genetic basis of nonresponse to hepatitis B vaccine in hemodialyzed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.064

Improved immunogenicity of a novel third-generation recombinant hepatitis B vaccine in patients with end-stage renal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.064

Rapid, enhanced, and persistent protection of patients with renal insufficiency by AS02(V)-adjuvanted hepatitis B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.064

Randomized trials published in some Chinese journals: how many are randomized?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.064

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.064

Vaccine recommendations for patients on chronic dialysis. The Advisory Committee on Immunization Practices and the American Academy of Pediatrics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.064

inferred from DOI database lookup

7 January 2021

based on heuristic

Is anti-hepatitis B virus (HBV) immunization successful in elderly hemodialysis (HD) patients?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.01.064

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2012.01.064

1 reference

13 December 2017

1 reference